Neutral
Niowave holds 12.18% of Aptevo (NASDAQ: APVO) — 151,723 shares
Niowave, Inc. has reported beneficial ownership of 151,723 shares of Aptevo Therapeutics Inc. common stock, which represents a 12.18% stake in the com...